Cefazolin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01327 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 50 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | infectious otitis media | KG + DL |
| 2 | bronchitis | KG + DL |
| 3 | middle ear disease | KG + DL |
| 4 | chronic otitis media | KG + DL |
| 5 | suppurative otitis media | KG + DL |
| 6 | otosalpingitis | KG + DL |
| 7 | non-suppurative otitis media | KG + DL |
| 8 | allergic otitis media | KG + DL |
| 9 | middle ear cholesterol granuloma | KG + DL |
| 10 | urinary tract infection (disease) | KG + DL |
| 11 | Ureaplasma urethritis | KG + DL |
| 12 | gonococcal urethritis | KG + DL |
| 13 | pneumonia | KG + DL |
| 14 | meningococcal infection | KG + DL |
| 15 | uterine inflammatory disease | KG + DL |
| 16 | xanthogranulomatous pyelonephritis | KG + DL |
| 17 | infectious otitis interna | KG + DL |
| 18 | staphylococcus aureus infection | KG + DL |
| 19 | geniculate herpes zoster | KG + DL |
| 20 | hyperamylasemia | KG + DL |
| 21 | polyclonal hyperviscosity syndrome | KG + DL |
| 22 | congenital analbuminemia | KG + DL |
| 23 | streptococcal meningitis | KG + DL |
| 24 | blood group incompatibility | KG + DL |
| 25 | premalignant hematological system disease | KG + DL |
| 26 | conjunctivitis | KG + DL |
| 27 | Lyme disease | KG + DL |
| 28 | ulcerative proctosigmoiditis | KG + DL |
| 29 | monoclonal gammopathy | KG + DL |
| 30 | postinfectious vasculitis | KG + DL |
| 31 | post-bacterial disorder | KG + DL |
| 32 | urogenital tuberculosis | KG + DL |
| 33 | post-infectious syndrome | KG + DL |
| 34 | hematological disease associated with an acquired peripheral neuropathy | KG + DL |
| 35 | paratyphoid fever | KG + DL |
| 36 | infective urethral stricture | KG + DL |
| 37 | chronic rhinosinusitis | KG + DL |
| 38 | epiglottitis | KG + DL |
| 39 | staphylococcal toxemia | KG + DL |
| 40 | chronic ethmoidal sinusitis | KG + DL |
| 41 | Chagas cardiomyopathy | KG + DL |
| 42 | infection-related hemolytic uremic syndrome | KG + DL |
| 43 | sinusitis | KG + DL |
| 44 | laryngotracheitis | KG + DL |
| 45 | punctate epithelial keratoconjunctivitis | KG + DL |
| 46 | pyelitis | KG + DL |
| 47 | paranasal sinus neoplasm (disease) | KG + DL |
| 48 | congenital hematological disorder | KG + DL |
| 49 | otitis externa | KG + DL |
| 50 | septicemic plague | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.